News | Robotic Systems | September 03, 2019

First-in-Human Telerobotic Coronary Intervention Procedures Published in EClinicalMedicine

Journal in The Lancet family publishes successful clinical results of remote PCI procedures using CorPath GRX Robotic System technology

First-in-Human Telerobotic Coronary Intervention Procedures Published in EClinicalMedicine

September 3, 2019 — Corindus Vascular Robotics Inc. announced that EClinicalMedicine, a clinical journal published by The Lancet, has published the results from the Telerobotic Intervention Study, the world’s first percutaneous coronary intervention (PCI) procedures conducted from a remote location outside the catheterization lab. The study was conducted using Corindus’ CorPath technology platform.

The paper, titled Long Distance Telerobotic-Assisted Percutaneous Coronary Intervention: First-in-Human Experience, discusses five successful patient cases performed by Tejas Patel, M.D., chairman and chief interventional cardiologist of the Apex Heart Institute in Ahmedabad, Gujarat, India. The five patients featured in the paper underwent elective PCI procedures from a distance of approximately 20 miles (32 kilometers) from Patel’s location inside the Swaminarayan Akshardham temple in Gandhinagar, Gujarat, India. His partner, Sanjay Shah, M.D., was onsite in the room with each patient at the Apex Heart Institute.

“I am honored to have been a part of this medical milestone,” stated Patel. “The application of telerobotics for remote treatment has the potential to impact a significant number of lives by providing access to specialized care that may not otherwise be possible. I am pleased to share my experience with the clinical community in such a well-respected publication that is part of the Lancet family,” added Patel.

Corindus developed the remote telerobotic interventional platform to deliver highly specialized and timely cardiovascular care to underserved patient populations with geographic barriers to treatment. The company is working on product development to enable use of the CorPath System in remote interventions and expand the company’s robotic platform to address stroke care.

For more information: www.corindus.com

 

Related Content

Corindus CorPath Used in World's First-in-Human Telerobotic Coronary Intervention

Corindus Vascular Robotics to Be Acquired by Siemens Healthineers

 

Reference

1. Patel T.M., Shah S.C., Pancholy S.B. Long Distance Tele-Robotic-Assisted Percutaneous Coronary Intervention: A Report of First-in-Human Experience. EClinicalMedicine, published online Sept. 3, 2019. https://doi.org/10.1016/j.eclinm.2019.07.017

Related Content

Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
FDA Grants Shockwave Medical Breakthrough Status for Coronary Intravascular Lithotripsy
News | Cath Lab | September 03, 2019
Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)...
Compound Could Help Improve Heart Attack Recovery
News | Cath Lab | August 27, 2019
Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy...
New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Overlay Init